Pharmcore Recalls Methylcobalamin Vials Due to Sterility Concerns
Pharmcore Inc. is recalling 1,115 vials of Methylcobalamin 10 mg due to a lack of assurance of sterility. The product was distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving sterility issues in injectable products which carry significant risk.
Plain-English summary
Pharmcore Inc. is recalling 1,115 vials of Methylcobalamin 10 mg Lyophilized. The recall was initiated because of a lack of assurance of sterility in the product. The affected lots are MTLY-19 (Expiration 10/31/2018) and MTLY-18 (Expiration 8/31/2018).
The recalled product was distributed nationwide. The FDA has classified this recall as Class II, indicating that use of or exposure to the product could cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Consumers and healthcare providers should stop using the recalled vials and contact Pharmcore Inc. or their supplier for further instructions on how to return or dispose of the product.
The recalled product
- Product
- Methylcobalamin 10 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009
- Manufacturer
- Pharmcore Inc.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 1,115
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: MTLY-19 Exp. 10/31/2018
- MTLY-18 Exp. 8/31/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 9 recalled by Pharmcore Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 9 products in this recall →Related recalls
Same manufacturer · Pharmcore Inc.
See all →- SeverePharmcore Recalls Human Chorionic Gonadotropin Vials Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SeverePharmcore Recalls Human Chorionic Gonadotropin Vials Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SeverePharmcore Recalls Human Chorionic Gonadotropin Vials Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SeverePharmcore Recalls Ipamorelin Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-09-05
- SeverePharmcore Recalls Ipamorelin Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-09-05
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29